Differential diagnosis between organic and inorganic mercury poisoning in human cases--the pathologic point of view

Area of Science:

• Neuropathology
• Toxicology

Background:

• Organic mercury, like methylmercury, causes characteristic brain damage seen in Minamata disease.
• Previous studies have described neuropathologic changes in acute organic mercury poisoning.

Purpose of the Study:

• To compare the neuropathologic differences between acute and chronic exposure to organic and inorganic mercury.
• To investigate the distribution and effects of mercury in the brain across different exposure types and durations.

Main Methods:

• Analysis of autopsy findings from patients with varying mercury exposure histories (methylmercury, mercury vapor, inorganic mercury).
• Histopathological examination of brain tissue, including assessment of neuronal loss, glial cell proliferation, and vascular changes.
• Mercury assays and histochemistry to determine mercury presence in brain tissue.

Main Results:

• Acute organic mercury poisoning (methylmercury) resulted in significant neuronal loss, glial proliferation, microcavitation, and edema in specific cerebral and cerebellar cortices.
• Chronic organic mercury poisoning showed similar neuropathologic changes (neuronal loss, glial proliferation) in affected brain regions.
• Acute inorganic mercury poisoning (mercury vapor) led to pneumonia, renal cortical necrosis, DIC, and infarctions in brain and kidneys.
• Chronic inorganic mercury poisoning showed no specific brain lesions, but mercury was detected in brain tissue.

Conclusions:

• Neuropathologic findings differ significantly between organic and inorganic mercury poisoning.
• Organic mercury primarily affects specific brain regions, causing neuronal loss and reactive gliosis.
• Inorganic mercury poisoning can cause systemic toxicity and varied brain effects, with mercury detectable in the brain even without apparent lesions.